Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/11/060197
CTRI/2023/11/060197
Not Yet Recruiting
N/A

A clinical study to evaluate the Safety and Efficacy of Panchakarma Essential in reducing symptomswith Cardiopulmonary Disorders - Nil

Mprex Healthcare Pvt.Ltd. Wakad, pune0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: I249- Acute ischemic heart disease, unspecified

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: I249- Acute ischemic heart disease, unspecified
Sponsor
Mprex Healthcare Pvt.Ltd. Wakad, pune
Status
Not Yet Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Mprex Healthcare Pvt.Ltd. Wakad, pune

Eligibility Criteria

Inclusion Criteria

  • •1\.Male and female subjects 30\-60 years of age (both inclusive).2\.Subjects diagnosed with Ischemic Heart Disease, Post Myocardial infarction, and Insomnia will be included.3\.Subjects with pulse rate more than 90 per minute.4\.An ambulatory subject can provide verbal and written consent and is ready to comply with all study procedures.

Exclusion Criteria

  • •1\.Female subjects, who are pregnant, breastfeeding, or planning to
  • •become pregnant.
  • •2\.History of major surgical intervention will be excluded.
  • •3\.History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
Phase 4
To evaluate the Safety and Efficacy of ACELABS Serum
CTRI/2024/02/063322Bright Diva Pte. Ltd.
Not Yet Recruiting
Phase 2
Effect of Decoction of Cuscuta Reflexa and local application of Saussurea Lappa and Honey in the management of Melasma.
CTRI/2021/03/032083Central Council of Research in Unani Medicine New Delhi
Not Yet Recruiting
Phase 4
To study the effect of Panchakarma Essential in male patients with anxiety.
CTRI/2023/07/055723Mprex Healthcare Pvt. Ltd.
Not Yet Recruiting
Phase 4
To study the effect of Panchakarma Essential in female patients with anxiety.
CTRI/2023/08/056234Mprex Healthcare Pvt. Ltd.
Not Yet Recruiting
Phase 4
To study the effect of Panchakarma Essential (Nirgundi-based formulation) in Knee Osteoarthritis.
CTRI/2023/07/055689Mprex Healthcare Pvt. Ltd.